Alphatec Holdings Inc. (ATEC), a medical equipment and supplies holding company, saw its stock soar 6.69% in pre-market trading on Thursday. This surge came after the company reported robust financial results for the fourth quarter of 2024 and provided an optimistic outlook for 2025.
In the fourth quarter, Alphatec achieved total revenue of $177 million, a remarkable 28% year-over-year increase and 17% sequential growth. The company's surgical revenue grew by 28% year-over-year to $157 million, while its EOS revenue rose by 32% to $20 million. Alphatec also reported positive free cash flow of $9 million for the first time since its transformation.
Looking ahead, Alphatec provided an optimistic revenue outlook for 2025, projecting approximately $732 million in revenue, representing a 20% growth rate. The company also forecasted an adjusted EBITDA of $75 million for the upcoming year. These positive financial projections, coupled with the strong fourth-quarter performance, likely fueled investor confidence and drove the pre-market surge in Alphatec's stock price.
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.